Comment on: Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease: Reply
Rheumatology (Oxford)
.
2024 Feb 9:keae105.
doi: 10.1093/rheumatology/keae105.
Online ahead of print.
Authors
Jennifer Hannah
1
2
,
Elisabetta A Renzoni
3
4
,
Patrick Gordon
1
2
3
Affiliations
1
Department of Academic Rheumatology, King's College London, UK.
2
Department of Rheumatology, King's College Hospitals NHS Trust, London, UK.
3
Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
4
Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.
PMID:
38337092
DOI:
10.1093/rheumatology/keae105
No abstract available